Dr. Josée Naegelen joins BIT as Vice President of Global Hematology Business Development
Montpellier, France, Nov 6, 2017 – BIT is glad to announce that Dr. Josée Naegelen has joined as Vice President of Global Hematology Business Development.
BIT has recently made impressive progress with our hematology business. Since launching our proprietary technology 3-Diff and 5-Diff hematology analyzers we have been successful to partner with leading life sciences companies to develop their hematology product lines. To ensure we continue to provide exceptional support to our clients, we are very pleased to announce that as of 2 November we have strengthened our team.
Dr. Josée Naegelen has joined our team as the Vice President of Global Hematology Business Development. She will be based in Montpellier, France and also spend time in Schwalbach, Germany to support our global key account clients and further grow our worldwide hematology business.
Josée comes to us with over 25 years of experience in the field of hematology. Prior to joining BIT she was with Beckman Coulter for 12 years, in her last position as Sr. Marketing Manager, Global Product Management and Strategy Hematology. Before this, she worked with Bayer Diagnostics and as a scientist in a university laboratory. Josée holds a doctorate degree in Pharmacy with a specialization on Clinical Pathology from the University of Besançon (France).
BIT provides contract product development, manufacturing and after-sales services, as well as hematology instruments, for life science, medical and IVD instrumentation OEMs. Quality and regulatory standards include GMP, FDA registered, ISO13485, QSR and CE IVD Directive. BIT‘s global operations in USA, Germany, France & China deliver precision engineered, cost effective systems solutions. Pre-engineered platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.
Valentin Kaiser, Marketing
Phone: +1 (858) 886 8350